Topic: research

The environmental impact and new application areas of bioderived materials were studied in the „Extending BioStyrene“ ER189 project, which ran from May to October, 2023.

Last week, the US Food and Drug Administration (FDA) approved the world's first vaccine against the chikungunya virus – Ixchiq. The vaccine candidate has been designed and manufactured at the University of Tartu. The human clinical trials were conducted by the biotechnology company Valneva Austria GmbH.

The project BeeYeast brought the grand prize at the iGEM (International Genetically Engineered Machine) competition, the world championship in synthetic biology.

The Estonian solar car team Solaride won third place in the Bridgestone World Solar Challenge in Australia at the end of October and got a special award for best performance in technical inspection.

The Teaming centres of excellence in digitalised bioengineering and personalised medicine at the University of Tartu are expected to become lighthouses in the region, attracting the best scientists and bringing change to the innovation landscape nationally and internationally.

Esmaspäeval, 11. septembril algusega kl 13.00 toimub Tartu Ülikooli aulas digitaalse bioinseneeria keskuse ning personaalmeditsiini teadus- ja arenduskeskuse avaüritus.

Estonia's research and economy would have much to gain from closer cooperation with the European Organization for Nuclear Research (CERN). However, this requires more thoughtful funding in the field of science in Estonia, which would ensure both the stability of research and a steady supply line of young researchers.

New bioderived recyclable filter materials will be developed

The task force of CERN meets with the University of Tartu’s Rector Toomas Asser, and pays a visit to the university’s Institute of Physics, the Institute of Technology and the Delta centre today.

doktoritöö